Medtecs International Corporation Limited (9103.TW)

TWD 6.25

(1.3%)

Net Debt Summary of Medtecs International Corporation Limited

Medtecs International Corporation Limited's latest annual net debt in 2023 was 4.6 Million USD , up 221.45% from previous year.
Medtecs International Corporation Limited's latest quarterly net debt in 2024 Q2 was 6.39 Million USD , up 101.76% from previous quarter.
Medtecs International Corporation Limited reported annual net debt of 1.43 Million USD in 2022, up 104.45% from previous year.
Medtecs International Corporation Limited reported annual net debt of -32.15 Million USD in 2021, up 29.39% from previous year.
Medtecs International Corporation Limited reported quarterly net debt of 4.6 Million USD for 2023 Q4, down -49.96% from previous quarter.
Medtecs International Corporation Limited reported quarterly net debt of 4.6 Million USD for 2023 FY, up 221.45% from previous quarter.

Annual Net Debt Chart of Medtecs International Corporation Limited (2023 - 2009)

Historical Annual Net Debt of Medtecs International Corporation Limited (2023 - 2009)

Year	Net Debt	Net Debt Growth
2023	4.6 Million USD	221.45%
2022	1.43 Million USD	104.45%
2021	-32.15 Million USD	29.39%
2020	-45.53 Million USD	-205.83%
2019	43.02 Million USD	18.56%
2018	36.29 Million USD	5.66%
2017	34.34 Million USD	17.32%
2016	29.27 Million USD	1.1%
2015	28.95 Million USD	-1.51%
2014	29.4 Million USD	-13.83%
2013	34.11 Million USD	-5.65%
2012	36.16 Million USD	-3.53%
2011	37.48 Million USD	-12.86%
2010	43.01 Million USD	33.31%
2009	32.27 Million USD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	6.39 Million USD	101.76%
2023 Q4	4.6 Million USD	-49.96%
2023 FY	4.6 Million USD	221.45%
2023 Q2	9.19 Million USD	542.35%
2022 FY	1.43 Million USD	104.45%
2022 Q4	1.43 Million USD	155.49%
2022 Q2	-2.57 Million USD	91.98%
2021 Q4	-32.15 Million USD	30.48%
2021 FY	-32.15 Million USD	29.39%
2021 Q2	-46.25 Million USD	-1.57%
2020 FY	-45.53 Million USD	-205.83%
2020 Q4	-45.53 Million USD	-291.4%
2020 Q2	23.79 Million USD	-44.71%
2019 FY	43.02 Million USD	18.56%
2019 Q4	43.02 Million USD	14.93%
2019 Q2	37.43 Million USD	3.15%
2018 Q2	34.82 Million USD	1.4%
2018 Q4	36.29 Million USD	4.21%
2018 FY	36.29 Million USD	5.66%
2017 Q2	30.57 Million USD	4.43%
2017 Q4	34.34 Million USD	12.34%
2017 FY	34.34 Million USD	17.32%
2016 Q4	29.27 Million USD	-4.88%
2016 FY	29.27 Million USD	1.1%
2016 Q2	30.77 Million USD	6.29%
2015 Q2	33.99 Million USD	15.64%
2015 FY	28.95 Million USD	-1.51%
2015 Q4	28.95 Million USD	-14.83%
2014 FY	29.4 Million USD	-13.83%
2014 Q4	29.4 Million USD	-9.03%
2014 Q2	32.31 Million USD	-5.28%
2013 FY	34.11 Million USD	-5.65%
2013 Q4	34.11 Million USD	-9.31%
2013 Q2	37.62 Million USD	4.03%
2012 FY	36.16 Million USD	-3.53%
2012 Q4	36.16 Million USD	-10.87%
2012 Q2	40.57 Million USD	8.24%
2011 FY	37.48 Million USD	-12.86%
2011 Q2	38.42 Million USD	-10.68%
2011 Q4	37.48 Million USD	-2.44%
2010 Q2	17.98 Million USD	-44.27%
2010 FY	43.01 Million USD	33.31%
2010 Q4	43.01 Million USD	139.21%
2009 Q2	33.36 Million USD	0.0%
2009 Q4	32.27 Million USD	-3.28%
2009 FY	32.27 Million USD	0.0%

Peer Net Debt Comparison of Medtecs International Corporation Limited

Name	Net Debt	Net Debt Difference
Nang Kuang Pharmaceutical Co., Ltd.	227.48 Million TWD	97.978%
Maxigen Biotech Inc.	-431.03 Million TWD	101.067%
SciVision Biotech Inc.	-163.18 Million TWD	102.819%
Bionime Corporation	2.42 Billion TWD	99.81%
Pegavision Corporation	63.52 Million TWD	92.759%
Visco Vision Inc.	563 Million TWD	99.183%